$SLS
SELLAS Life Sciences Group, Inc. Stock $sls

$sls Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000139047818000035 Filed on November 14, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.640M	$1.341M	$5.990M
YoY Change	-55.93%	-58.38%	-222.24%
% of Gross Profit
Research & Development	$3.650M	$1.720M	$710.0K
YoY Change	414.08%	61.05%	-118.44%
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
% of Gross Profit
Operating Expenses	$6.290M	$3.061M	$8.580M
YoY Change	-26.69%	-28.65%	-198.17%
Operating Profit
YoY Change
Interest Expense	$30.00K	-$70.00K	-$6.060M
YoY Change	-100.5%	-30.0%	-54.61%
% of Operating Profit
Other Income/Expense, Net	$950.0K	-$290.0K	$180.0K
YoY Change	427.78%	-93.4%	-103.15%
Pretax Income	-$14.86M	-$290.0K	-$7.920M
YoY Change	87.63%	-93.39%	-6.93%
Income Tax	-$1.540M	$0.00	$250.0K
% Of Pretax Income
Net Earnings	-$13.32M	-$290.0K	$2.440M
YoY Change	-645.9%	-93.49%	597.14%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$30.27M	-$828.6K	$20.33M
COMMON SHARES
Basic Shares Outstanding	22.03M shares	19.57M shares	45.71M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.300M	$10.00M	$2.300M
YoY Change	130.43%	-22.48%	-61.67%
Cash & Equivalents	$5.337M	$10.00M	$2.319M
Short-Term Investments
Other Short-Term Assets	$500.0K	$1.300M	$10.70M
YoY Change	-95.33%	-90.51%	2575.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables		$6.600M	$0.00
Total Short-Term Assets	$5.838M	$17.81M	$13.09M
YoY Change	-55.39%	-33.15%	105.16%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$1.900M	$1.914M	$1.914M
YoY Change	-0.73%	-64.46%	-67.55%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$700.0K	$1.100M	$900.0K
YoY Change	-22.22%	1000.0%
Total Long-Term Assets	$11.08M	$20.66M	$20.44M
YoY Change	-45.8%	-10.0%	49751.22%
TOTAL ASSETS
Total Short-Term Assets	$5.838M	$17.81M	$13.09M
Total Long-Term Assets	$11.08M	$20.66M	$20.44M
Total Assets	$16.92M	$38.47M	$33.53M
YoY Change	-49.55%	-22.43%	422.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.755M	$7.238M	$11.69M
YoY Change	-67.88%	3330.33%	1291.79%
Accrued Expenses	$2.219M	$4.683M	$3.201M
YoY Change	-30.68%	46.99%	-20.94%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$76.00K	$8.377M
YoY Change	-100.0%	-99.38%	-48.91%
Total Short-Term Liabilities	$5.974M	$12.00M	$24.57M
YoY Change	-75.68%	-57.19%	326.69%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$2.611M
YoY Change	-100.0%		-54.19%
Other Long-Term Liabilities	$5.300M	$6.300M	$2.600M
YoY Change	103.85%	384.62%
Total Long-Term Liabilities	$0.00	$0.00	$2.611M
YoY Change	-100.0%	-100.0%	-54.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.974M	$12.00M	$24.57M
Total Long-Term Liabilities	$0.00	$0.00	$2.611M
Total Liabilities	$11.67M	$20.01M	$31.46M
YoY Change	-62.9%	-42.75%	175.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$81.86M	-$68.53M	-$54.19M
YoY Change	51.07%	-79.18%	78.06%
Common Stock	$87.10M	$86.99M	$56.26M
YoY Change	54.83%	-74.98%	121.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.245M	$18.46M	$2.070M
YoY Change
Total Liabilities & Shareholders Equity	$16.92M	$38.47M	$33.53M
YoY Change	-49.55%	-22.43%	422.21%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q4
OPERATING ACTIVITIES
Net Income	-$13.32M	-$290.0K	$2.440M
YoY Change	-645.9%	-93.49%	597.14%
Depreciation, Depletion And Amortization	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Operating Activities	-$4.550M	-$14.17M	-$1.740M
YoY Change	161.49%	490.42%	-106.94%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00		$12.16M
YoY Change	-100.0%		1166.67%
Cash From Investing Activities	$0.00		$12.16M
YoY Change	-100.0%		1153.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-80.00K	14.25M	-120.0K
YoY Change	-33.33%	-142600.0%	-99.26%
NET CHANGE
Cash From Operating Activities	-4.550M	-14.17M	-1.740M
Cash From Investing Activities	0.000		12.16M
Cash From Financing Activities	-80.00K	14.25M	-120.0K
Net Change In Cash	-4.630M	80.00K	10.30M
YoY Change	-144.95%	-103.32%	5.32%
FREE CASH FLOW
Cash From Operating Activities	-$4.550M	-$14.17M	-$1.740M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001390478
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22026476	shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SELLAS Life Sciences Group, Inc.
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Trading Symbol TradingSymbol	SLS
	gale	Change In Fair Value Of Common Stock Warrants Issued In Connection With Various Equity Financings ChangeInFairValueOfCommonStockWarrantsIssuedInConnectionWithVariousEquityFinancings	0	USD
	gale	Change In Fair Value Of Common Stock Warrants Issued In Connection With Various Equity Financings ChangeInFairValueOfCommonStockWarrantsIssuedInConnectionWithVariousEquityFinancings	5340000	USD
	gale	Change In Fair Value Of Contingent Purchase Consideration ChangeInFairValueOfContingentPurchaseConsideration	0	USD
	gale	Change In Fair Value Of Contingent Purchase Consideration ChangeInFairValueOfContingentPurchaseConsideration	-4025000	USD
CY2017Q3	gale	Change In Fair Value Of Contingent Purchase Price Consideration ChangeInFairValueOfContingentPurchasePriceConsideration	0	USD
	gale	Change In Fair Value Of Contingent Purchase Price Consideration ChangeInFairValueOfContingentPurchasePriceConsideration	0	USD
CY2017Q3	gale	Dividend On Conversion Of Series A Convertible Preferred Stock Most Favored Nation DividendOnConversionOfSeriesAConvertiblePreferredStockMostFavoredNation	0	USD
	gale	Dividend On Conversion Of Series A Convertible Preferred Stock Most Favored Nation DividendOnConversionOfSeriesAConvertiblePreferredStockMostFavoredNation	0	USD
CY2018Q3	gale	Change In Fair Value Of Contingent Purchase Price Consideration ChangeInFairValueOfContingentPurchasePriceConsideration	-162000	USD
	gale	Change In Fair Value Of Contingent Purchase Price Consideration ChangeInFairValueOfContingentPurchasePriceConsideration	-4025000	USD
	gale	Change In Fair Value Of Warrant Liabilities ChangeInFairValueOfWarrantLiabilities	5340000	USD
CY2018Q3	gale	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Prefunded ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsPrefunded	0.0001
	gale	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	2525000	shares
	gale	Classof Warrantor Right Canceled Or Expired ClassofWarrantorRightCanceledOrExpired	541000	shares
	gale	Classof Warrantor Right Granted ClassofWarrantorRightGranted	21327000	shares
	gale	Classof Warrantor Right Surrenderedand Canceledto Purchase Common Stock ClassofWarrantorRightSurrenderedandCanceledtoPurchaseCommonStock	121667	shares
CY2017Q4	gale	Classof Warrantor Right Term ClassofWarrantorRightTerm	P5Y
CY2018Q3	gale	Classof Warrantor Right Term ClassofWarrantorRightTerm	P5Y
CY2018Q3	gale	Closing Price Of Common Stock ClosingPriceOfCommonStock	1.22
CY2018Q3	gale	Common Stock Capital Shares Reserved For Future Issuance Of Employee Stock Purchase Plan CommonStockCapitalSharesReservedForFutureIssuanceOfEmployeeStockPurchasePlan	115000	shares
	gale	Common Stock Issued During The Period For Cancellation Of Warrants CommonStockIssuedDuringThePeriodForCancellationOfWarrants	54613	shares
	gale	Common Stock Shares Acquiredin Exchangefor Warrants CommonStockSharesAcquiredinExchangeforWarrants	412667	shares
CY2018Q3	gale	Consideration Exchanged Fair Value ConsiderationExchangedFairValue	1200000	USD
CY2017Q4	gale	Contingent Purchase Price Consideration Net Of Current Portion ContingentPurchasePriceConsiderationNetOfCurrentPortion	1294000	USD
CY2018Q3	gale	Contingent Purchase Price Consideration Net Of Current Portion ContingentPurchasePriceConsiderationNetOfCurrentPortion	5319000	USD
CY2017Q4	gale	Contract Research Payable ContractResearchPayable	51000	USD
CY2018Q3	gale	Contract Research Payable ContractResearchPayable	583000	USD
	gale	Convertible Preferred Stock Dividends ConvertiblePreferredStockDividends	487000	USD
	gale	Debt Instrument Redemption Principal Amount Redeemed DebtInstrumentRedemptionPrincipalAmountRedeemed	2800000	USD
	gale	Debt Instrument Redemption Principal Amount Redeemed Settled In Cash DebtInstrumentRedemptionPrincipalAmountRedeemedSettledInCash	600000	USD
CY2018Q3	gale	Debt Instrument Redemption Principal Amount Redeemed Shares DebtInstrumentRedemptionPrincipalAmountRedeemedShares	659529	shares
	gale	Dividend Modification Of Warrants DividendModificationOfWarrants	-491000	USD
	gale	Dividend On Conversion Of Series A Convertible Preferred Stock DividendOnConversionOfSeriesAConvertiblePreferredStock	4436000	USD
CY2018Q3	gale	Dividend On Conversion Of Series A Convertible Preferred Stock Most Favored Nation DividendOnConversionOfSeriesAConvertiblePreferredStockMostFavoredNation	8700000	USD
CY2018Q3	gale	Dividend On Conversion Of Series A Convertible Preferred Stock Most Favored Nation DividendOnConversionOfSeriesAConvertiblePreferredStockMostFavoredNation	8654000	USD
	gale	Dividend On Conversion Of Series A Convertible Preferred Stock Most Favored Nation DividendOnConversionOfSeriesAConvertiblePreferredStockMostFavoredNation	8654000	USD
	gale	Dividend On Conversion Of Series A Convertible Preferred Stock Most Favored Nation DividendOnConversionOfSeriesAConvertiblePreferredStockMostFavoredNation	8700000	USD
	gale	Employee Service Share Based Compensation Unrecognized Compensation Costs EmployeeServiceShareBasedCompensationUnrecognizedCompensationCosts	1200000	USD
	gale	Employee Service Share Based Compensation Unrecognized Compensation Costs Weighted Average Period Of Recognition EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsWeightedAveragePeriodOfRecognition	P2Y5M16D
	gale	Fair Value Of Parent Company Common Stock Issued In Exchange For Services FairValueOfParentCompanyCommonStockIssuedInExchangeForServices	325000	USD
	gale	Fair Value Of Parent Company Common Stock Issued In Exchange For Services FairValueOfParentCompanyCommonStockIssuedInExchangeForServices	0	USD
	gale	Fair Value Of Warrants Canceled FairValueOfWarrantsCanceled	524000	USD
	gale	Fair Value Of Warrants Exercise Price Adjustment FairValueOfWarrantsExercisePriceAdjustment	491000	USD
	gale	Fair Value Of Warrants Issued In Connection With Common Stock Recorded As Cost Of Equity FairValueOfWarrantsIssuedInConnectionWithCommonStockRecordedAsCostOfEquity	5039000	USD
CY2017Q4	gale	Fair Value Of Warrants Liabilities FairValueOfWarrantsLiabilities	1309000	USD
CY2018Q3	gale	Fair Value Of Warrants Liabilities FairValueOfWarrantsLiabilities	975000	USD
CY2017Q4	gale	Fair Value Of Warrants Potentially Settleable In Cash FairValueOfWarrantsPotentiallySettleableInCash	1309000	USD
CY2018Q3	gale	Fair Value Of Warrants Potentially Settleable In Cash FairValueOfWarrantsPotentiallySettleableInCash	975000	USD
	gale	Fair Valueof Warrants Granted FairValueofWarrantsGranted	5039000	USD
CY2017Q4	gale	Fair Valueof Warrants Grantedper Share FairValueofWarrantsGrantedperShare	5.60
	gale	Gain Loss On Extinguishment Of Payables GainLossOnExtinguishmentOfPayables	-634000	USD
	gale	Gain Loss On Extinguishment Of Payables GainLossOnExtinguishmentOfPayables	0	USD
CY2017Q4	gale	In Process Research Development InProcessResearchDevelopment	17600000	USD
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	4.92
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11691000	USD
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	7238000	USD
CY2018Q3	gale	In Process Research Development InProcessResearchDevelopment	17600000	USD
	gale	Increase Decrease In Fair Value Of Warrant Liability IncreaseDecreaseInFairValueOfWarrantLiability	0	USD
CY2018Q3	gale	Increase Decrease In Fair Value Of Warrant Liability IncreaseDecreaseInFairValueOfWarrantLiability	500000	USD
	gale	Increase Decrease In Fair Value Of Warrant Liability IncreaseDecreaseInFairValueOfWarrantLiability	500000	USD
	gale	Increase Decrease In Fair Value Of Warrant Liability IncreaseDecreaseInFairValueOfWarrantLiability	491000	USD
CY2017Q3	gale	Liability Classified Warrants Antidilution Protection LiabilityClassifiedWarrantsAntidilutionProtection	0	USD
	gale	Liability Classified Warrants Antidilution Protection LiabilityClassifiedWarrantsAntidilutionProtection	0	USD
CY2018Q3	gale	Liability Classified Warrants Antidilution Protection LiabilityClassifiedWarrantsAntidilutionProtection	491000	USD
	gale	Liability Classified Warrants Antidilution Protection LiabilityClassifiedWarrantsAntidilutionProtection	491000	USD
	gale	Longterm Debt Issued In Connection With Warrant Exchanges LongtermDebtIssuedInConnectionWithWarrantExchanges	0	USD
	gale	Longterm Debt Issued In Connection With Warrant Exchanges LongtermDebtIssuedInConnectionWithWarrantExchanges	966000	USD
	gale	Loss On Settlement Of Liability Classified Warrants LossOnSettlementOfLiabilityClassifiedWarrants	0	USD
	gale	Loss On Settlement Of Liability Classified Warrants LossOnSettlementOfLiabilityClassifiedWarrants	727000	USD
CY2017Q3	gale	Loss On Settlement Of Warrants Liability LossOnSettlementOfWarrantsLiability	0	USD
	gale	Loss On Settlement Of Warrants Liability LossOnSettlementOfWarrantsLiability	0	USD
CY2018Q3	gale	Loss On Settlement Of Warrants Liability LossOnSettlementOfWarrantsLiability	0	USD
	gale	Loss On Settlement Of Warrants Liability LossOnSettlementOfWarrantsLiability	727000	USD
CY2018Q3	gale	Options Reserved For Future Issuance Under Companies Incentive Plan OptionsReservedForFutureIssuanceUnderCompaniesIncentivePlan	381000	shares
	gale	Preferred Stock Issued During Period Value New Issues PreferredStockIssuedDuringPeriodValueNewIssues	9647000	USD
CY2017Q4	gale	Rebates And Returns Of Former Commercial Products RebatesAndReturnsOfFormerCommercialProducts	223000	USD
CY2018Q3	gale	Rebates And Returns Of Former Commercial Products RebatesAndReturnsOfFormerCommercialProducts	22000	USD
	gale	Reclassification Of Warrant Liabilities Upon Exchange For Shares Of Common Stock ReclassificationOfWarrantLiabilitiesUponExchangeForSharesOfCommonStock	0	USD
	gale	Reclassification Of Warrant Liabilities Upon Exchange For Shares Of Common Stock ReclassificationOfWarrantLiabilitiesUponExchangeForSharesOfCommonStock	285000	USD
CY2018Q3	gale	Restricted Stock Shares Reservedfor Future Issuance RestrictedStockSharesReservedforFutureIssuance	13000	shares
	gale	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue	0	USD
	gale	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateAggregateIntrinsicValue	0	USD
	gale	Warrant Exchange Agreements Amount WarrantExchangeAgreementsAmount	285000	USD
CY2018Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	11900000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3201000	USD
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4683000	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1744000	USD
CY2018Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2836000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	56254000	USD
CY2018Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	86987000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	257000	USD
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	-4436000	USD
	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	284000	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	5039000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1267000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3776000	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	136000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	284000	USD
CY2017Q4	us-gaap	Assets Assets	33526000	USD
CY2018Q3	us-gaap	Assets Assets	38470000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	13087000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	17807000	USD
CY2017Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-1.61
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	4.92
CY2017Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-1.61
CY2017Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-9066000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-21690000	USD
CY2017Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3300000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3300000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2319000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9968000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10000000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5962000	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2369000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12750000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10082000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3593000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2668000	USD
CY2017Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.42
CY2018Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6.59
CY2018Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.10
CY2018Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2017Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	316163	shares
CY2018Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	11520000	shares
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	963000	shares
CY2018Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	19224000	shares
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	20167000	shares
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5766891	shares
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20501476	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5766891	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20501476	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5766891	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	2000	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	3587000	USD
CY2018Q3	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	7871186	USD
CY2018Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	3748184	shares
CY2017Q3	us-gaap	Costs And Expenses CostsAndExpenses	4290000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	14429000	USD
CY2018Q3	us-gaap	Costs And Expenses CostsAndExpenses	3061000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	15246000	USD
CY2017Q3	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	5800000	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	5800000	USD
CY2017Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	10988000	USD
CY2018Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	76000	USD
	us-gaap	Decrease In Restricted Cash DecreaseInRestrictedCash	1800000	USD
CY2017Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	10200000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	377000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1673000	USD
CY2018Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1722000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	7000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	49000	USD
CY2017Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	925000	USD
CY2018Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	1149000	USD
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.27
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.56
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.53
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.75
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	566000	USD
CY2018Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	808000	USD
CY2017Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2018Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2241000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5340000	USD
CY2017Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	766000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	766000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	1914000	USD
CY2018Q3	us-gaap	Goodwill Goodwill	1914000	USD
CY2017Q3	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	5200000	USD
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	5200000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-14969000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-14347000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	63000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	180000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	163000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4453000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	85000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	182000	USD
	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	0	USD
	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	474000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	0	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	6600000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	538000	USD
CY2017Q3	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	500000	USD
CY2017Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	0	USD
CY2018Q3	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	474000	USD
CY2017Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-102000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-360000	USD
CY2018Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-74000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-292000	USD
	us-gaap	Interest Paid Net InterestPaidNet	321000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1250000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	31456000	USD
CY2018Q3	us-gaap	Liabilities Liabilities	20013000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33526000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	38470000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	24569000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	11997000	USD
CY2017Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	1300000	USD
CY2018Q3	us-gaap	Litigation Reserve Current LitigationReserveCurrent	0	USD
CY2018Q3	us-gaap	Long Term Debt LongTermDebt	100000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8377000	USD
CY2018Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	76000	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2611000	USD
CY2018Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5654000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	23199000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9247000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-25867000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-4455000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-14969000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-290000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-14347000	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4455000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14969000	USD
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9435000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-27928000	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4392000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14789000	USD
CY2018Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-290000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14184000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	191000	USD
CY2018Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	276000	USD
CY2017Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-102000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-360000	USD
CY2018Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2771000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1062000	USD
CY2017Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	0	USD
CY2018Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	6600000	USD
CY2018Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	6600000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	258000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	134000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	487000	USD
CY2017Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2018Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4436000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	337000	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	651000	USD
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	0	USD
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	166000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6007000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	21564000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	0	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	9647000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	353000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7525000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1068000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5079000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1720000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5116000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10431000	USD
CY2018Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	114000	USD
CY2018Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	100000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-54185000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-68532000	USD
CY2018Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	21600000	USD
CY2018Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.10
CY2018Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.10
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3222000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9350000	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1341000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10130000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3776000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	284000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.8083
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0273
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	43000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	265.35
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	59000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	483000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.73
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	434000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1240.55
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	34.17
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	0	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.24
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.24
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y2M12D
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y6M4D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y3M4D
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P10Y
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	21564000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	2070000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	18457000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2070000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18457000	USD
CY2017Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	426000	USD
CY2018Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	158000	USD
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1962822	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	3284351	shares
CY2018Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	17635671	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	10161153	shares

Files In Submission

Name	View Source	Status
0001390478-18-000035-index-headers.html	Edgar Link	pending
0001390478-18-000035-index.html	Edgar Link	pending
0001390478-18-000035.txt	Edgar Link	pending
0001390478-18-000035-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gale-20180930.xml	Edgar Link	completed
gale-20180930.xsd	Edgar Link	pending
gale-20180930_cal.xml	Edgar Link	unprocessable
gale-20180930_def.xml	Edgar Link	unprocessable
gale-20180930_lab.xml	Edgar Link	unprocessable
gale-20180930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sellas-logoa05.jpg	Edgar Link	pending
Show.js	Edgar Link	pending
sls-20180930x10q.htm	Edgar Link	pending
sls20180930ex311.htm	Edgar Link	pending
sls20180930ex312.htm	Edgar Link	pending
sls20180930ex321.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SLS
SELLAS Life Sciences Group, Inc. Stock $sls

2018 Q4 Form 10-Q Financial Statement

#000139047818000035 Filed on November 14, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SLS SELLAS Life Sciences Group, Inc. Stock $sls

2018 Q4 Form 10-Q Financial Statement

#000139047818000035 Filed on November 14, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SLS
SELLAS Life Sciences Group, Inc. Stock $sls